INSULIN DETEMIR and MALAISE

Overview

MALAISE is the #9 most commonly reported adverse reaction for INSULIN DETEMIR, manufactured by Novo Nordisk. There are 1,203 FDA adverse event reports linking INSULIN DETEMIR to MALAISE. This represents approximately 1.8% of all 67,881 adverse event reports for this drug.

Patients taking INSULIN DETEMIR who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

MALAISE is a less commonly reported adverse event for INSULIN DETEMIR, but still significant enough to appear in the safety profile.

Other Side Effects of INSULIN DETEMIR

In addition to malaise, the following adverse reactions have been reported for INSULIN DETEMIR:

• BLOOD GLUCOSE INCREASED — 6,220 reports
• NAUSEA — 1,971 reports
• BLOOD GLUCOSE DECREASED — 1,568 reports
• FATIGUE — 1,534 reports
• DIARRHOEA — 1,398 reports
• DRUG INEFFECTIVE — 1,366 reports
• VOMITING — 1,312 reports
• DYSPNOEA — 1,293 reports
• FALL — 1,189 reports
• DIZZINESS — 1,161 reports

Other Drugs Associated with MALAISE

The following drugs have also been linked to malaise in FDA adverse event reports:

Does INSULIN DETEMIR cause MALAISE?

MALAISE has been reported as an adverse event in 1,203 FDA reports for INSULIN DETEMIR. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is MALAISE with INSULIN DETEMIR?

MALAISE accounts for approximately 1.8% of all adverse event reports for INSULIN DETEMIR, making it a notable side effect.

What should I do if I experience MALAISE while taking INSULIN DETEMIR?

If you experience malaise while taking INSULIN DETEMIR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages